Net Cash Provided by (Used in) Financing Activities in USD of Accelerate Diagnostics, Inc from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Accelerate Diagnostics, Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2011 to 2024.
  • Accelerate Diagnostics, Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $11.4M.
  • Accelerate Diagnostics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $27.1M, a 200% increase from 2023.
  • Accelerate Diagnostics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $9.02M, a 71.5% decline from 2022.
  • Accelerate Diagnostics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $31.6M, a 26.8% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Accelerate Diagnostics, Inc Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $11.4M +$11.5M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 -$77K -$154K -200% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $77K -$11.8M -99.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $11.9M +$10.4M +730% Jan 1, 2021 Mar 31, 2021 10-Q/A 2023-03-03
Q1 2020 $1.43M -$2.39M -62.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $3.82M -$98M -96.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $102M +$99.8M +4910% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $2.03M +$2.83M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 -$799K -$829K -2763% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q1 2015 $30K -$694K -95.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 $724K -$19.4M -96.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q1 2013 $20.1M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q3 2012 $100K -$28.6K -22.2% Aug 1, 2012 Oct 31, 2012 10-Q 2012-12-14
Q3 2011 $129K Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-14

Accelerate Diagnostics, Inc Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $27.1M +$18M +200% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-21
2023 $9.02M -$22.6M -71.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-21
2022 $31.6M -$11.6M -26.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $43.2M +$31.6M +272% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-29
2020 $11.6M +$4.81M +70.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-31
2019 $6.82M -$119M -94.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
2018 $126M +$35.3M +39.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-02
2017 $90.4M +$88.7M +5032% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $1.76M -$103M -98.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $105M +$59.1M +129% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $45.7M +$4.81M +11.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $40.9M +$26.3M +181% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-09
2012 $14.5M +$14.4M +7383% Aug 1, 2011 Jul 31, 2012 10-K 2015-02-26
2011 $194K Aug 1, 2010 Jul 31, 2011 10-K 2014-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.